Curaizon

Improving Healthcare, Reducing Costs & Saving Lives

CuraServe™ is a complete healthcare ecosystem that improves drug adherence and brings game-changing benefits to patients and healthcare providers. We use a series of outreach tools and messages, supported by predictive modeling and behavioural analytics, to increase the rate of drug adherence. As our CuraServe™ solution helps patients, it’s also generating a vast amount of patient data. That data is then anonymised and made available through CuraData™. The only way that pharmaceutical companies, academics and researchers can access this data by purchasing CuraTokens™. Curaizon™ is unique because our CuraServe™ solution generates the information that drives the value of our CuraData™ platform. We’re not simply offering another way of storing, sharing or mining data. Our data is the first-of-its-kind insight into real-time patient behaviour and adherence. Through our collaborations with research institutions, national health services and biotech companies, we shall create one of the most powerful and valuable data sources in healthcare. Our data and analytics will finally give the health and pharmaceutical industries the tools they have been looking for to bring about the change patients need. Leveraging our contracts with healthcare providers, we can quickly build an ecosystem of mutually beneficial stakeholders within the value chain.

Roadmap

1

CuraServe™ Development Begins.

2

CuraServe™ Testing Underway.

3

CuraServe™ Alpha Release Complete.

4

Token Presale Begins.

5

Token Public Sale Begins.

6

CuraData™ Beta Release Complete.

7

CuraServe™ Public Release.

8

CuraData™ Platform Growth.

9

Curadata™ 2.0 Release.

Team

Nicholas James Rumble

Chief Executive Officer (CEO)

linkedin

Chris Matey

Chief Financial Officer (CFO)

linkedin

Darran Trute

Chief Technology Officer (CTO)

linkedin

Andrey Verbitsky

Tokenomics Expert

linkedin

Luke Lerdal

Chief Data Officer (CDO)

linkedin

Rory McCrea

Advisor

linkedin

Sarah Chilvers

Advisor

linkedin

Rating

Pre-sale start

06/01/18

d h m s

Schedule

PRE-SALE

from 06/01/18 to 06/08/18

TOKEN SALE

from 06/08/18 to 10/31/18

Details

Platform: Ethereum

Hard Cap: 25,000,000 USD

Token Symbol: ctkn

Total Supply of Tokens: 500,000,000

Tokens Available for Sale: 250,000,000 CTKN (50%)

KYC: true

Can’t participate: United States (Total Restriction)

Accepts: ETH

Registered Company: United Kingdom